Blood conservation approaches in surgical patients;Épargne transfusionnelle en chirurgie orthopédique

Transfusion Clinique et Biologique

Volumn 15, Issue 5, 2008, Pages 294-302

  Rosencher, N ^a   Bellamy, L ^a   Chabbouh, T ^a   Arnaout, L ^a   Ozier, Y ^a  

^a AP HP ^*  (France)

Author keywords

Antifibrinolytics; Autologous transfusion; Recombinant human erythropoietin

Indexed keywords

APROTININ; ERYTHROPOIETIN; HEMOGLOBIN; TRANEXAMIC ACID; ANTIANEMIC AGENT; FERRIC ION; FERRITIN; IRON(III) HYDROXIDE SUCROSE COMPLEX; IRON(III)-HYDROXIDE SUCROSE COMPLEX; RECOMBINANT ERYTHROPOIETIN; SUCROSE; UNCLASSIFIED DRUG;

ANESTHESIA INDUCTION; ARTHROPLASTY; ARTICLE; BLEEDING; BLOOD CONSERVATION; BLOOD TRANSFUSION; CLINICAL EFFECTIVENESS; DEATH; EMBOLISM; FRANCE; HUMAN; PERIOPERATIVE PERIOD; PREOPERATIVE CARE; PREOPERATIVE PERIOD; RISK ASSESSMENT; SURGICAL PATIENT; THERAPY DELAY; ANEMIA; BLOOD; BLOOD AUTOTRANSFUSION; DRUG ADMINISTRATION; HEMODILUTION; ORTHOPEDIC SURGERY; PEROPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; REVIEW; TIME;

ANEMIA; APROTININ; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; BLOOD TRANSFUSION, AUTOLOGOUS; DRUG ADMINISTRATION SCHEDULE; ERYTHROPOIETIN, RECOMBINANT; FERRIC COMPOUNDS; FERRITINS; HEMATINICS; HEMODILUTION; HUMANS; INTRAOPERATIVE COMPLICATIONS; ORTHOPEDIC PROCEDURES; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE CARE; SUCROSE; TIME FACTORS; TRANEXAMIC ACID;

EID: 54849407337     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tracli.2008.09.024     Document Type: Article

References (32)

1. Lienhart A., Auroy Y., Pequignot F., Benhamou D., Warszawski J., Bovet M., et al. Survey of anesthesia-related mortality in France. Anesthesiology 105 6 (2006) 1087-1097
2. DGS/DH/AFS. circulaire 97/57 relative à la transfusion autologue en chirurgie. JO. 1997.
3. Daurat G., Duedari N., and Schved J.F. The decrease of preoperative autologous transfusion in France has not been linked to an increase of homologous red cell concentrates. Ann Fr Anesth Reanim 27 2 (2008 Feb) 141-147
4. Eledjam J.J., Schved J.F., and Bonnafoux J. Physiology of hemostasis. Ann Fr Anesth Reanim 4 3 (1985) 35A-42A
5. Schved J.F. Do we need autologous blood donation?. Ann Fr Anesth Reanim 23 5 (2004 May) 468-473
6. Schved J.F., Gris J.C., Gilly D., Joubert P., Eledjam J.J., and d'Athis F. Fibrinolytic activity in traumatic hemothorax fluids. Ann Fr Anesth Reanim 10 2 (1991) 104-107
7. Spiess B.D., Sassetti R., McCarthy R.J., Narbone R.F., Tuman K.J., and Ivankovich A.D. Autologous blood donation: hemodynamics in a high-risk patient population. Transfusion 32 1 (1992) 17-22
8. Lienhart A. Les risques de la transfusion et de la non-transfusion en France. Gazette Transfus 199 (2006) 6-10
9. Toy P.T., Strauss R.G., Stehling L.C., Sears R., Price T.H., Rossi E.C., et al. Predeposited autologous blood for elective surgery. A national multicenter study. N Engl J Med 316 9 (1987) 517-520
10. Forgie M., Wells P., Laupacis A., and fergusson D. Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red blood cell transfusion: results of a meta-analysis. International Study of Perioperative Transfusion (ISPOT) Investigators. Arch Intern Med 158 (1998) 610-616
11. Etchason J., Petz L., Keeler E., Calhoun L., Kleinman S., Snider C., et al. The cost effectiveness of preoperative autologous blood donations. N Engl J Med 332 11 (1995) 719-724
12. Rosencher N., Kerkkamp H.E., Macheras G., Munuera L.M., Menichella G., Barton D.M., et al. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 43 4 (2003) 459-469
13. Goodnough L.T. The case against universal WBC reduction (and for the practice of evidence-based medicine). Transfusion 40 12 (2000 Dec) 1522-1527
14. Goodnough L.T., Rudnick S., Price T.H., Ballas S.K., Collins M.L., Crowley J.P., et al. Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy. N Engl J Med 321 17 (1989) 1163-1168
15. Price T., Goodnough L., Vogler W., Sacher R., Hellman R., Johnston M., et al. Improving the efficacy of preoperative autologous blood donation in patients with low hematocrit: a randomized, double-blind, controlled trial of recombinant human erythropoietin. Am J Med 101 (1996) 22S-27S
16. De Andrade J., Jove M., Landon G., Frei D., Guilfoyle M., and Young D. Baseline hemoglobin as a predictor of risk of transfusion and response to Epoetin alfa in orthopedic surgery patients. Am J Orthop 25 (1996) 533-542
17. Rosencher N., Poisson D., Albi A., Aperce M., Barré J., and Samama C.M. Two injections of erythropoietin (EPO) correct moderate anemia in most patients awaiting orthopedic surgery. Can J Anaesth 52 2 (2005) 160-165
18. Goodnough L.T., Skikne B., and Brugnara C. Erythropoietin, iron, and erythropoiesis. Blood 96 3 (2000 Aug 1) 823-833
19. De Andrade J., Frei D., and Guilfoyle M. Integrated analysis of thrombotic/vascular event occurence in epoietin alfa. Treated patients undergoing major, elective orthopedic surgery. Orthopedics 22 1/Supplement (1999) 111-118
20. Bryson G., Laupacis A., and Wells G. Does acute normovolemic hemodilution reduce perioperative allogeneic transfusion? A meta-analysis. The International Study of Perioperative Transfusion. Anesth Analg 86 (1998) 9-15
21. Samama C.M., Langeron O., Rosencher N., Capdevila X., Rouche P., Pegoix M., et al. Aprotinin versus placebo in major orthopedic surgery: a randomized, double-blinded, dose-ranging study. Anesth Analg 95 2 (2002) 287-293
22. Alderman M.H. JNC V revisited: standard of care or individualized treatment for hypertension?. Am Heart J 135 2 Pt 2 (1998) S8-S15
23. Mangano D.T., Tudor I.C., and Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med 354 4 (2006 Jan 26) 353-365
24. Zufferey P., Merquiol F., Laporte S., Decousus H., Mismetti P., Auboyer C., et al. Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?. Anesthesiology 105 5 (2006 Nov) 1034-1046
25. Cid J., and Lozano M. Tranexamic acid reduces allogeneic red cell transfusions in patients undergoing total knee arthroplasty: results of a meta-analysis of randomized controlled trials. Transfusion 45 8 (2005 Aug) 1302-1307
26. Dahl O.E., Aspelin T., Arnesen H., Seljeflot I., Kierulf P., Ruyter R., et al. Increased activation of coagulation and formation of late deep venous thrombosis following discontinuation of thromboprophylaxis after hip replacement surgery. Thromb Res 80 4 (1995 Nov 15) 299-306
27. Wilson D., Cooke E.A., McNally M.A., Wilson H.K., Yeates A., and Mollan R.A. Changes in coagulability as measured by thrombelastography following surgery for proximal femoral fracture. Injury 32 10 (2001) 765-770
28. Hansen E., Wolff N., Knuechel R., and Ruschoff J. Tumor cells in blood shed from the surgical Field. Arch Surg 130 (1995) 387-393
29. Bull B.S., and Bull M.H. The salvaged blood syndrome: a sequel to mechanochemical activation of platelets and leucocytes?. Blood Cells 16 (1990) 5-23
30. Innerhofer P., Wiedermann F.J., Tiefenthaler W., Schobersberger W., Klingler A., Velik-Salchner C., et al. Are leukocytes in salvaged washed autologous blood harmful for the recipient? The results of a pilot study. Anesth Analg 93 3 (2001) 566-572
31. Arnestad J.P., Bengtsson A., Bengtson J.P., Tylman M., Redl H., and Schlag G. Formation of cytokines by retransfusion of shed whole blood. Br J Anaesth 72 (1994) 422-425
32. Haute autorité de santé. Récupération de sang périopératoire (RSPO) : suivie de son administration par voie veineuse. www.has-santefr. 2006 ;Juillet.